Bio-Techne Co. (NASDAQ:TECH) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Offer Predictions for GameStop Corp.’s Q1 2026 Earnings (NYSE:GME)
Next post Zacks Research Research Analysts Decrease Earnings Estimates for Plexus Corp. (NASDAQ:PLXS)